Presenting clinical features of patients with vitreoretinal lymphoma

Table 1 Demographic and clinical features of patients with vitreoretinal lymphoma

Patient No.	Age/gender	Bilateral involvement (Y/N)	Presenting ocular symptoms	Symptom onset (days prior to presentation)	Presenting visual acuity	Exam findings	Time from presentation to diagnosis (d)
1	83 yr/F	N	Cloudy vision	30	20/20	Vitreous cells	120
2	65 yr/F	Y	Worsening floaters and blurred vision	120	20/60	Vitreous cells	17
3	86 yr/F	Y	Worsening floaters and blurred vision	365	CF 1’	Vitreous haze and subretinal lesions	45
4	68 yr/M	Y	Blurred vision	Unable to determine	20/60	Vitreous cells and subretinal lesions	30
5	70 yr/F	Y	Cloudy vision	60	20/40	Vitreous cells	16
6	67 yr/M	N	Worsening floaters and blurred vision	7	20/100	Subretinal lesion	180
7	81 yr/M	Y	Blurred vision	14	20/80	Vitreous cells/haze	30
8	58 yr/M	Y	Worsening floaters and blurred vision	21	20/150	Vitreous haze and subretinal lesions	45
9	63 yr/M	N	Blurred vision	90	20/400	Vitreous cells and subretinal lesions	24

F/M: Female/Male; Y/N: Yes/No; CF 1’: Counting fingers at 1 foot.